TY - STD TI - WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization; 2013. http://www.who.int/hiv/pub/guidelines/arv2013. Accessed 26 Jan 2016. UR - http://www.who.int/hiv/pub/guidelines/arv2013 ID - ref1 ER - TY - STD TI - Ministry of Health, Republic of Uganda. Addendum to the national antiretroviral treatment guidelines. December 2013. http://preventcrypto.org/wp-content/uploads/2012/07/Uganda-National-ART-Guidelines_2014.pdf. Accessed 15 Jan 2015. UR - http://preventcrypto.org/wp-content/uploads/2012/07/Uganda-National-ART-Guidelines_2014.pdf ID - ref2 ER - TY - STD TI - Ministry of Health, Republic of Kenya, (NASCOP). NAaSCP. Guidelines on use of antiretroviral drugs for treating and preventing HIV infection: a rapid advice, 2014. http://guidelines.health.go.ke:8000/media/Rapid_Advice_Booklet_2014_July_V5.pdf. Accessed 17 Feb 2016. UR - http://guidelines.health.go.ke:8000/media/Rapid_Advice_Booklet_2014_July_V5.pdf ID - ref3 ER - TY - STD TI - Ministry of Health and Social Welfare, The United Republic of Tanzania, Programme. NAC. The United Republic of Tanzania. National guidelines for the management of HIV and AIDS. 5th edn, May, 2015. http://www.nacp.go.tz/site/publications/care-and-treatment/ NationalGuidelineforManagementHIV.pdf. Accessed 15 Feb 2016. UR - http://www.nacp.go.tz/site/publications/care-and-treatment/ ID - ref4 ER - TY - JOUR AU - Hall, A. M. AU - Hendry, B. M. AU - Nitsch, D. AU - Connolly, J. O. PY - 2011 DA - 2011// TI - Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence JO - Am J Kidney Dis VL - 57 UR - https://doi.org/10.1053/j.ajkd.2011.01.022 DO - 10.1053/j.ajkd.2011.01.022 ID - Hall2011 ER - TY - JOUR AU - Squires, K. E. PY - 2001 DA - 2001// TI - An introduction to nucleoside and nucleotide analogues JO - Antivir Ther VL - 6 ID - Squires2001 ER - TY - JOUR AU - Jülg, B. D. AU - Bogner, J. R. AU - Crispin, A. AU - Goebel, F. -. D. PY - 2005 DA - 2005// TI - Progression of renal impairment under therapy with tenofovir JO - AIDS VL - 19 UR - https://doi.org/10.1097/01.aids.0000180109.03759.35 DO - 10.1097/01.aids.0000180109.03759.35 ID - Jülg2005 ER - TY - JOUR AU - Zimmermann, A. E. AU - Pizzoferrato, T. AU - Bedford, J. AU - Morris, A. AU - Hoffman, R. AU - Braden, G. PY - 2006 DA - 2006// TI - Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions JO - Clin Infect Dis VL - 42 UR - https://doi.org/10.1086/499048 DO - 10.1086/499048 ID - Zimmermann2006 ER - TY - JOUR AU - Gallant, J. E. AU - Winston, J. A. AU - DeJesus, E. AU - Pozniak, A. L. AU - Chen, S. -. S. AU - Cheng, A. K. PY - 2008 DA - 2008// TI - The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients JO - AIDS VL - 22 UR - https://doi.org/10.1097/QAD.0b013e3283112b8e DO - 10.1097/QAD.0b013e3283112b8e ID - Gallant2008 ER - TY - JOUR AU - Ryom, L. AU - Mocroft, A. AU - Kirk, O. AU - Worm, S. W. AU - Kamara, D. A. AU - Reiss, P. PY - 2013 DA - 2013// TI - Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D: A: D study JO - J Infect Dis VL - 207 UR - https://doi.org/10.1093/infdis/jit043 DO - 10.1093/infdis/jit043 ID - Ryom2013 ER - TY - JOUR AU - Labarga, P. AU - Barreiro, P. AU - Martin-Carbonero, L. AU - Rodriguez-Novoa, S. AU - Solera, C. AU - Medrano, J. PY - 2009 DA - 2009// TI - Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir JO - AIDS VL - 23 UR - https://doi.org/10.1097/QAD.0b013e3283262a64 DO - 10.1097/QAD.0b013e3283262a64 ID - Labarga2009 ER - TY - JOUR AU - Laprise, C. AU - Baril, J. -. G. AU - Dufresne, S. AU - Trottier, H. PY - 2013 DA - 2013// TI - Association between tenofovir exposure and reduced kidney function in a cohort of HIV-positive patients: results from 10 years of follow-up JO - Clin Infect Dis VL - 56 UR - https://doi.org/10.1093/cid/cis937 DO - 10.1093/cid/cis937 ID - Laprise2013 ER - TY - JOUR AU - Oboho, I. AU - Abraham, A. AU - Benning, L. AU - Anastos, K. AU - Sharma, A. AU - Young, M. PY - 2013 DA - 2013// TI - Tenofovir use and urinary biomarkers among HIV-infected women in the Women’s Interagency HIV Study (WIHS) JO - J Acquir Immune Defic Syndr VL - 62 UR - https://doi.org/10.1097/QAI.0b013e31828175c9 DO - 10.1097/QAI.0b013e31828175c9 ID - Oboho2013 ER - TY - JOUR AU - Gupta, S. K. PY - 2008 DA - 2008// TI - Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system JO - AIDS Patient Care STDS VL - 22 UR - https://doi.org/10.1089/apc.2007.0052 DO - 10.1089/apc.2007.0052 ID - Gupta2008 ER - TY - JOUR AU - Sax, P. E. AU - Wohl, D. AU - Yin, M. T. AU - Post, F. AU - DeJesus, E. AU - Saag, M. PY - 2015 DA - 2015// TI - Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials JO - Lancet VL - 385 UR - https://doi.org/10.1016/S0140-6736(15)60616-X DO - 10.1016/S0140-6736(15)60616-X ID - Sax2015 ER - TY - JOUR AU - Patel, K. K. AU - Patel, A. K. AU - Ranjan, R. R. AU - Patel, A. R. AU - Patel, J. K. PY - 2010 DA - 2010// TI - Tenofovir-associated renal dysfunction in clinical practice: an observational cohort from western India JO - Indian J Sex Transm Dis. VL - 31 UR - https://doi.org/10.4103/0253-7184.68998 DO - 10.4103/0253-7184.68998 ID - Patel2010 ER - TY - JOUR AU - Izzedine, H. AU - Isnard-Bagnis, C. AU - Hulot, J. -. S. AU - Vittecoq, D. AU - Cheng, A. AU - Jais, C. K. PY - 2004 DA - 2004// TI - Renal safety of tenofovir in HIV treatment-experienced patients JO - AIDS VL - 18 UR - https://doi.org/10.1097/00002030-200404300-00019 DO - 10.1097/00002030-200404300-00019 ID - Izzedine2004 ER - TY - JOUR AU - Franey, C. AU - Knott, D. AU - Barnighausen, T. AU - Dedicoat, M. AU - Adam, A. AU - Lessells, R. J. PY - 2009 DA - 2009// TI - Renal impairment in a rural African antiretroviral programme JO - BMC Infect Dis VL - 9 UR - https://doi.org/10.1186/1471-2334-9-143 DO - 10.1186/1471-2334-9-143 ID - Franey2009 ER - TY - JOUR AU - Wools-Kaloustian, K. AU - Gupta, S. K. AU - Muloma, E. AU - Owino-Ong’or, W. AU - Sidle, J. AU - Aubrey, R. W. PY - 2007 DA - 2007// TI - Renal disease in an antiretroviral-naive HIV-infected outpatient population in Western Kenya JO - Nephrol Dial Transplant VL - 22 UR - https://doi.org/10.1093/ndt/gfm223 DO - 10.1093/ndt/gfm223 ID - Wools-Kaloustian2007 ER - TY - JOUR AU - Reid, A. AU - Stöhr, W. AU - Walker, A. S. AU - Williams, I. G. AU - Kityo, C. AU - Hughes, P. PY - 2008 DA - 2008// TI - Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy JO - Clin Infect Dis VL - 46 UR - https://doi.org/10.1086/533468 DO - 10.1086/533468 ID - Reid2008 ER - TY - JOUR AU - Cooper, R. D. AU - Wiebe, N. AU - Smith, N. AU - Keiser, P. AU - Naicker, S. AU - Tonelli, M. PY - 2010 DA - 2010// TI - Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients JO - Clin Infect Dis VL - 51 UR - https://doi.org/10.1086/655681 DO - 10.1086/655681 ID - Cooper2010 ER - TY - STD TI - WHO. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. September 2015. http://who.int/hiv/pub/guidelines/earlyrelease-arv/en/ Accessed 12 Jan 2016. UR - http://who.int/hiv/pub/guidelines/earlyrelease-arv/en/ ID - ref22 ER - TY - JOUR AU - Mugyenyi, P. AU - Walker, A. S. AU - Hakim, J. AU - Munderi, P. AU - Gibb, D. M. AU - Kityo, C. PY - 2010 DA - 2010// TI - Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial JO - Lancet VL - 375 UR - https://doi.org/10.1016/S0140-6736(09)62067-5 DO - 10.1016/S0140-6736(09)62067-5 ID - Mugyenyi2010 ER - TY - JOUR AU - Morgan, D. AU - Malamba, S. S. AU - Maude, G. H. AU - Okongo, M. J. AU - Wagner, H. U. AU - Mulder, D. W. PY - 1997 DA - 1997// TI - An HIV-1 natural history cohort and survival times in rural Uganda JO - AIDS VL - 11 UR - https://doi.org/10.1097/00002030-199705000-00011 DO - 10.1097/00002030-199705000-00011 ID - Morgan1997 ER - TY - JOUR AU - Kyaw, N. T. T. AU - Harries, A. D. AU - Chinnakali, P. AU - Antierens, A. AU - Soe, K. P. AU - Woodman, M. PY - 2015 DA - 2015// TI - Low incidence of renal dysfunction among HIV-infected patients on a Tenofovir-based first line antiretroviral treatment regimen in Myanmar JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0135188 DO - 10.1371/journal.pone.0135188 ID - Kyaw2015 ER - TY - JOUR AU - Peyrière, H. AU - Reynes, J. AU - Rouanet, I. AU - Daniel, N. AU - Boever, C. M. AU - Mauboussin, J. -. M. PY - 2004 DA - 2004// TI - Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases JO - J Acquir Immune Defic Syndr VL - 35 UR - https://doi.org/10.1097/00126334-200403010-00007 DO - 10.1097/00126334-200403010-00007 ID - Peyrière2004 ER - TY - JOUR AU - Nelson, M. R. AU - Katlama, C. AU - Montaner, J. S. AU - Cooper, D. A. AU - Gazzard, B. AU - Clotet, B. PY - 2007 DA - 2007// TI - The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years JO - AIDS VL - 21 UR - https://doi.org/10.1097/QAD.0b013e3280b07b33 DO - 10.1097/QAD.0b013e3280b07b33 ID - Nelson2007 ER - TY - JOUR AU - Madeddu, G. AU - Bonfanti, P. AU - Giuseppe, V. AU - Carradori, S. AU - Grosso, C. AU - Marconi, P. PY - 2008 DA - 2008// TI - Tenofovir renal safety in HIV-infected patients: results from the SCOLTA project JO - Biomed Pharmacother VL - 62 UR - https://doi.org/10.1016/j.biopha.2007.04.008 DO - 10.1016/j.biopha.2007.04.008 ID - Madeddu2008 ER - TY - JOUR AU - Fernandez-Fernandez, B. AU - Montoya-Ferrer, A. AU - Sanz, A. B. AU - Sanchez-Nino, M. D. AU - Izquierdo, M. C. AU - Poveda, J. PY - 2011 DA - 2011// TI - Tenofovir nephrotoxicity: 2011 update JO - AIDS Res Treat VL - 2011 ID - Fernandez-Fernandez2011 ER - TY - JOUR AU - Goicoechea, M. AU - Liu, S. AU - Best, B. AU - Sun, S. AU - Jain, S. AU - Kemper, C. PY - 2008 DA - 2008// TI - Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy JO - J Infect Dis VL - 197 UR - https://doi.org/10.1086/524061 DO - 10.1086/524061 ID - Goicoechea2008 ER - TY - JOUR AU - Lucas, G. M. AU - Ross, M. J. AU - Stock, P. G. AU - Shlipak, M. G. AU - Wyatt, C. M. AU - Gupta, S. K. PY - 2014 DA - 2014// TI - Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America JO - Clin Infect Dis VL - 59 UR - https://doi.org/10.1093/cid/ciu617 DO - 10.1093/cid/ciu617 ID - Lucas2014 ER - TY - JOUR AU - Scherzer, R. AU - Estrella, M. AU - Li, Y. AU - Choi, A. I. AU - Deeks, S. G. AU - Grunfeld, C. PY - 2012 DA - 2012// TI - Association of tenofovir exposure with kidney disease risk in HIV infection JO - AIDS. VL - 26 UR - https://doi.org/10.1097/QAD.0b013e328351f68f DO - 10.1097/QAD.0b013e328351f68f ID - Scherzer2012 ER - TY - JOUR AU - Gara, N. AU - Zhao, X. AU - Collins, M. AU - Chong, W. AU - Kleiner, D. AU - Jake Liang, T. PY - 2012 DA - 2012// TI - Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B JO - Aliment Pharmacol Ther VL - 35 UR - https://doi.org/10.1111/j.1365-2036.2012.05093.x DO - 10.1111/j.1365-2036.2012.05093.x ID - Gara2012 ER -